HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY

被引：0

作者：

Bertamini, L. ^{[1
]}

Stefanoni, P. ^{[1
]}

Tacchetti, P. ^{[1
]}

Ledda, A. ^{[1
]}

Palmas, A. ^{[1
]}

Gentile, M. ^{[1
]}

Palmieri, S. ^{[1
]}

Annibali, O. ^{[1
]}

Musolino, C. ^{[1
]}

Burdisso, M. ^{[1
]}

Capra, A. ^{[1
]}

Rizzi, R. ^{[1
]}

Molica, S. ^{[1
]}

Cellini, C. ^{[1
]}

Monaco, F. ^{[1
]}

De Sabbata, G. ^{[1
]}

Cea, M. ^{[1
]}

Rivolti, E. ^{[1
]}

Fazio, F. ^{[1
]}

Musto, P. ^{[1
]}

Boccadoro, M. ^{[1
]}

Gay, F. ^{[1
]}

机构：

[1] European Myeloma Network, Turin, Italy

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C008

引用

页码：12 / 13

页数：2

共 50 条

[21] Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China [J].

Mei, Jiangang ;

Zhai, Yongping ;

Li, Hanqing ;

Li, Feng ;

Zhou, Xiaogang ;

Song, Ping ;

Zhao, Qian ;

Yu, Yaping ;

An, Zhiming ;

Wang, Liping .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (11) :2263-2273

[22] Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China [J].

Jiangang Mei ;

Yongping Zhai ;

Hanqing Li ;

Feng Li ;

Xiaogang Zhou ;

Ping Song ;

Qian Zhao ;

Yaping Yu ;

Zhiming An ;

Liping Wang .

Journal of Cancer Research and Clinical Oncology, 2018, 144 :2263-2273

[23] Treatment options for multiple myeloma patients with high-risk disease [J].

Ailawadhi, Sikander ;

Masood, Aisha ;

Sher, Taimur ;

Miller, Kena C. ;

Wood, Margaret ;

Lee, Kelvin ;

Chanan-Khan, Asher .

MEDICAL ONCOLOGY, 2010, 27 :53-61

[24] Treatment options for multiple myeloma patients with high-risk disease [J].

Sikander Ailawadhi ;

Aisha Masood ;

Taimur Sher ;

Kena C. Miller ;

Margaret Wood ;

Kelvin Lee ;

Asher Chanan-Khan .

Medical Oncology, 2010, 27 :53-61

[25] Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma [J].

Nahi, Hareth ;

Afram, Gabriel ;

Uttervall, Katarina ;

Lockmer, Sandra ;

Tatting, Love ;

Gahrton, Gosta ;

Kashif, Muhammad ;

Alici, Evren ;

Stromberg, Olga ;

Klimkowska, Monika ;

Lund, Johan .

CANCER MEDICINE, 2023, 12 (22) :20736-20744

[26] A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma [J].

Muz, Barbara ;

de la Puente, Pilar ;

Azab, Feda ;

Luderer, Micah John ;

King, Justin ;

Vij, Ravi ;

Azab, Abdel Kareem .

BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (01) :70-81

[27] Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma [J].

Mocellin, S ;

Del Fiore, P ;

Guarnieri, L ;

Scalerta, R ;

Foletto, M ;

Chiarion, V ;

Pilati, P ;

Nitti, D ;

Lise, M ;

Rossi, CR .

INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) :741-745

[28] Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics [J].

Kumar, Shaji ;

Fonseca, Rafael ;

Ketterling, Rhett P. ;

Dispenzieri, Angela ;

Lacy, Martha Q. ;

Gertz, Morie A. ;

Hayman, Suzanne R. ;

Buadi, Francis K. ;

Dingli, David ;

Knudson, Ryan A. ;

Greenberg, Alexandra ;

Russell, Stephen J. ;

Zeldenrust, Steven R. ;

Lust, John A. ;

Kyle, Robert A. ;

Bergsagel, Leif ;

Rajkumar, S. Vincent .

BLOOD, 2012, 119 (09) :2100-2105

[29] Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition [J].

Granell, Miquel ;

Calvo, Xavier ;

Garcia-Guinon, Antoni ;

Escoda, Lourdes ;

Abella, Eugenia ;

Ma Martinez, Clara ;

Teixido, Montserrat ;

Teresa Gimenez, Ma ;

Senin, Alicia ;

Sanz, Patricia ;

Campoy, Desiree ;

Vicent, Ana ;

Arenillas, Leonor ;

Rosinol, Laura ;

Sierra, Jorge ;

Blade, Joan ;

Fernandez de Larrea, Carlos .

HAEMATOLOGICA, 2017, 102 (06) :1099-1104

[30] Kinetics and Biology of Circulating Tumor Cells (CTCs) and Measurable Residual Disease (MRD): Two Dynamic High-Risk Clones in Multiple Myeloma (MM) [J].

Guerrero, Camila ;

Termini, Rosalinda ;

Garces, Juan-Jose ;

Jose Calasanz, Maria ;

Rios, Rafael ;

Cabezudo, Elena ;

Rosinol, Laura ;

Joan, Bargay ;

Perez-Montana, Albert ;

Oriol Rocafiguera, Albert ;

Cabanas Perianes, Valentin ;

Najera, Maria-Josefa ;

Garcia, Esther Gonzalez ;

Ocio, Enrique M. ;

Sureda Balari, Anna Maria ;

De Arriba, Felipe ;

Hernandez Garcia, Miguel Teodoro ;

Garcia, Antonio ;

Martinez-Lopez, Joaquin ;

Blanchard, Maria-Jesus ;

Gonzalez Perez, Marta Sonia ;

Iglesias, Rebeca ;

Orfao, Alberto ;

Victoria Mateos, Maria ;

Lahuerta Palacios, Juan Jose ;

Blade, Joan ;

San-Miguel, Jesus ;

Cedena, Maria T. ;

Puig, Noemi ;

Paiva, Bruno .

BLOOD, 2023, 142

← 1 2 3 4 5 →